Get the latest market trends in your inbox

Stay on top of the latest market trends and economic insights with the Axios Markets newsletter. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Denver news in your inbox

Catch up on the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Des Moines news in your inbox

Catch up on the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Minneapolis-St. Paul news in your inbox

Catch up on the most important stories affecting your hometown with Axios Minneapolis-St. Paul

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tampa-St. Petersburg news in your inbox

Catch up on the most important stories affecting your hometown with Axios Tampa-St. Petersburg

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

J. Scott Applewhite / AP

It's about stocks, again. CNN notices the Georgia Republican, who is Trump's nominee to lead HHS, introduced legislation delaying regulation on a company in which he'd recently purchased stock. The transition team says there's no scandal — the purchase was made by a broker and Price didn't know about it until after the bill was introduced.

What happened:

  • The Centers for Medicare and Medicaid Services proposed a new way to pay for drugs under Medicare Part B last year. It was ultimately withdrawn by the administration after the election, but drew vehement industry and congressional criticism.
  • Price, then chair of the House Budget Committee, bought stock in Zimmer Biomet shortly before introducing the delay bill. Analysts had said the Zimmer Biomet, a medical device manufacturer, would be significantly hurt by the regulation.
  • Zimmer Biomet's political action committee then contributed to Price's re-election campaign.
  • In a statement Monday night, the transition team said the purchase happened because Price's broker was doing a larger rebalancing of his portfolio and he didn't know about it until later.

What's next: If this sounds familiar, it's because Price's stock purchases have come up repeatedly in the past couple weeks, raising ethical questions. But the real question is whether it's a big enough deal to sink his nomination.

So far, the answer seems to be probably not. "It's hardly surprising he introduced a bill to overturn a badly written reg," said one Senate GOP aide. The aide also pointed out the bill had likely been drafted for awhile before it was introduced, which is standard law-writing process.

Go deeper

1 hour ago - Science

The "war on nature"

A resident stands on his roof as the Blue Ridge Fire burned back in October in Chino Hills, Calif. Photo: Jae C. Hong/AP

Apocalyptic weather is the new normal because humans are "waging war on nature," the UN declared on Wednesday.

What they're saying: "The state of the planet is broken," said UN Secretary-General António Guterres, reports AP. “This is suicidal.”

Updated 3 hours ago - Politics & Policy

Coronavirus dashboard

Illustration: Aïda Amer/Axios

  1. Health: Nursing homes are still getting pummeledU.S. could hit herd immunity by end of summer 2021 if Americans embrace virus vaccines, Fauci says.
  2. Politics: Pelosi, Schumer call on McConnell to adopt bipartisan $900B stimulus framework.
  3. World: U.K. clears Pfizer-BioNTech vaccine for mass rollout — Putin says Russia will begin large-scale vaccination next week.
  4. Business: Investors are finally starting to take their money out of safe-haven Treasuries.
  5. Sports: The end of COVID’s grip on sports may be in sight.

Pelosi, Schumer call on McConnell to adopt bipartisan $900B stimulus framework

House Speaker Nancy Pelosi on Nov. 20. Photo: Drew Angerer/Getty Images

House Speaker Nancy Pelosi (D-Calif.) and Senate Minority Leader Chuck Schumer (D-N.Y.) on Wednesday urged Senate Majority Leader Mitch McConnell (R-Ky.) to use a $908 billion bipartisan coronavirus relief framework as a basis for jumpstarting negotiations.

Why it matters: The framework, introduced by a group of bipartisan senators on Tuesday, calls for significantly less funding than Pelosi had previously demanded — a sign that Democrats are ready to further compromise as millions of Americans endure economic hardship.